ANXA1 is reported as a positive regulator of EphA2 in Nasopharyngeal Carcinoma, gastric and colon cancer, targeting which can decrease EphA2 protein to suppress the cancer cells63, 64. This evidence concerns the gene ANXA1 and malignant colon neoplasm.